MustGrow Biologics Corp. (TSXV:MGRO)
0.4100
-0.0400 (-8.89%)
Sep 2, 2026, 3:56 PM EST
MustGrow Biologics Revenue
MustGrow Biologics had revenue of 74.79K CAD in the quarter ending June 30, 2026, a decrease of -76.09%. This brings the company's revenue in the last twelve months to 1.83M, up 317.12% year-over-year. In the year 2025, MustGrow Biologics had annual revenue of 8.29M with 6,501.87% growth.
Revenue (ttm)
1.83M
Revenue Growth
+317.12%
P/S Ratio
3.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
31.70M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.29M | 8.16M | 6,501.87% |
| Dec 31, 2024 | 125.52K | -4.59M | -97.34% |
| Dec 31, 2023 | 4.71M | 4.71M | 72,630.36% |
| Dec 31, 2022 | 6.48K | -6.39K | -49.65% |
| Dec 31, 2021 | 12.87K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 2.00K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
MustGrow Biologics News
- 2 days ago - MustGrow Biologics Earnings Call Transcript: Q2 2026 - Transcripts
- 2 days ago - MustGrow Biologics Registration statement: Q2 2026 - Filings
- 2 days ago - MustGrow Biologics Registration statement: Q2 2026 - Filings
- 2 days ago - MustGrow Biologics Earnings release: Q2 2026 - Filings
- 6 days ago - MustGrow Announces Second Quarter 2026 Financial Results - Newsfile Corp
- 9 days ago - Market One: MustGrow Biologics Receives First Bayer Milestone Payment - Newsfile Corp
- 9 days ago - First Bayer milestone payment received for mustard-based biocontrol - BNN Bloomberg
- 12 days ago - MustGrow Receives First Milestone Payment from Bayer AG - Newsfile Corp